Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Side effects rinvoq?

See the DrugPatentWatch profile for rinvoq

What side effects does Rinvoq (upadacitinib) cause?

Rinvoq (upadacitinib) can cause a range of side effects. Commonly reported effects include infections and gastrointestinal symptoms. Serious risks can also occur, including blood clots and certain lab abnormalities (based on the drug’s safety profile and prescribing information).

What are the most common Rinvoq side effects?

People taking Rinvoq often report side effects that may include:
- Upper respiratory or other infections
- Nausea, diarrhea, or other stomach-area complaints
- Headache

What serious side effects should you watch for?

Rinvoq carries warnings for potentially serious complications. Patients taking it are typically advised to seek urgent care for signs such as:
- Serious infection symptoms (for example, fever, worsening cough, or feeling very unwell)
- Blood clot symptoms (such as one-sided leg swelling/pain, chest pain, or shortness of breath)
- Signs of liver problems (such as yellowing of the skin/eyes or dark urine)
- Allergic reaction symptoms (swelling of face/lips, trouble breathing, rash)

Why does Rinvoq raise infection risk?

Rinvoq is an immunosuppressive medication (it targets Janus kinase, JAK). By changing immune signaling, it can reduce the body’s ability to fight infections, which is why clinicians monitor patients closely and screen for infections before starting.

What lab changes are linked to Rinvoq?

Rinvoq can affect blood counts and other lab measures. Your prescriber may order periodic blood tests to monitor for things like:
- Changes in white blood cell or red blood cell counts
- Changes in liver enzymes
- Lipid (cholesterol) increases

What should patients tell their doctor before starting Rinvoq?

Before or while taking Rinvoq, doctors commonly ask about:
- History of recurrent or serious infections
- Tuberculosis exposure or prior TB
- Prior blood clots or risk factors for clotting
- Hepatitis or other chronic infections
- Current medications, because combining with other immunosuppressants can increase risks

When should you stop Rinvoq or call your doctor urgently?

Contact your clinician right away for symptoms suggesting a serious infection, blood clot, severe allergic reaction, or liver problems. Do not adjust or stop Rinvoq without medical guidance, but prompt evaluation is important when red-flag symptoms appear.

How do Rinvoq side effects compare with other JAK inhibitors?

Side effects across JAK inhibitors often overlap (for example, infection risk and lab changes). Differences can occur in the frequency and specific warning profiles seen for each drug. If you’re choosing between treatments, your clinician can compare the risk factors that matter most for you.

Where can I read the official safety information for Rinvoq?

For detailed safety warnings, monitoring guidance, and prescribing information, you can use DrugPatentWatch.com (which tracks drug regulatory and patent-related material) as a starting point: https://www.drugpatentwatch.com/

---

Sources

  1. DrugPatentWatch.com - Rinvoq (upadacitinib)


Other Questions About Rinvoq :

Is there a generic for rinvoq? What are the side effects of rinvoq for arthritis? What are the long term side effects of rinvoq? Does rinvoq work? Does rinvoq work for ulcerative colitis? Rinvoq for eczema? Can rinvoq cause weight gain?